At Cryoport Systems, our biobanking solutions offer more than just storage – they provide a comprehensive approach to sample management. With strict adherence to regulatory requirements and industry standards, we offer the highest level of quality and compliance. Learn More: https://cyrx.co/4bL14jr #SampleManagement #Compliance $CYRX
Cryoport Systems
Transportation, Logistics, Supply Chain and Storage
Brentwood, TN 21,246 followers
Keep in-touch with innovative, integrated supply chain solutions for the Life Sciences
About us
Cryoport Systems is a market leader in globally integrated temperature-controlled supply chain support for critical, irreplaceable products and materials in the Life Sciences industry. We are already trusted to support over 650 active clinical trials and we support the leading commercial therapies worldwide, delivering unparalleled, integrated supply chain services for products, therapies and treatments requiring unique, specialized temperature-controlled management. As the Life Sciences constantly evolve and advance, so do we.
- Website
-
https://linktr.ee/Cryoport
External link for Cryoport Systems
- Industry
- Transportation, Logistics, Supply Chain and Storage
- Company size
- 1,001-5,000 employees
- Headquarters
- Brentwood, TN
- Type
- Public Company
- Founded
- 1999
- Specialties
- Cryogenics, liquid nitrogen, LN2, drug trial, CRO, cold chain, human tissue shipping, animal tissue shipping, biotech clinical trial, contract research organization, life sciences research, diagnostics, lab moves, regenerative therapy, and regenerative medicine
Locations
Employees at Cryoport Systems
-
Jerrell Shelton
-
Gerry Sorge
-
Frank Steffen
🔹 IT Director 🔹 Senior IT Manager 🔹 IT Manager 🔹 IT Operations 🔹 Project Manager 🔹 Leadership 🔹 Strategy 🔹 Infrastructure 🔹 Cloud 🔹…
-
Mark Flower
VP Business Development | Cell & Gene Therapy Enthusiast | Liverpool FC Fan | @markflower@bsky.social
Updates
-
Ensuring reliable and consistent leukapheresis starting materials is a critical challenge for cell therapies. Variability in fresh versus cryopreserved materials impacts manufacturability, scalability, and patient outcomes. Join industry experts for a roundtable discussion this Thursday, December 12 on strategies to overcome these challenges, including advancements in cryopreservation, site standardization, and integrated supply chain solutions. Register now to secure your spot: https://lnkd.in/gZ--vT7c
-
Product integrity and patient safety are paramount for the Cell and Gene Therapy Industry, requiring scalable and reliable transportation of temperature-sensitive biologics. The latest article from Cell & Gene Therapy Insights, Next-generation risk mitigation in the temperature-controlled supply chain for advanced therapies with ISO 21973 compliance, explores these complex challenges and evaluates traceability, and risk mitigation strategies along the supply chain, centering operations around ISO 21973 guidelines. Discover how Cryoport Systems’ state-of-the-art innovations further enhance the safety and integrity of these sensitive therapies along the entire supply chain journey. https://lnkd.in/g2e_9KBK #EnablingtheOutcome
-
Gene therapy promises to revolutionize medicine, but the logistics behind transporting these sensitive therapies present unique challenges. The Cryoport Elite® Ultra Cold shipping system is designed specifically for high-stakes shipments requiring ultra-low temperatures. Learn how we're Enabling the Outcome™ for gene therapy by addressing temperature control, product integrity, near real-time monitoring, and sustainability. Learn More: https://lnkd.in/gN6xnU4N
-
Trust Cryoport Systems to manage your critical materials with precision. Our temperature-controlled logistics solutions ensure the safe distribution of your cell therapies. #CriticalMaterialsManagement #LogisticsPrecision #Quality $CYRX Learn More: https://cyrx.co/3yYwuVA
-
Cryoport Systems continues to connect with leaders in hematology at #ASH24. If you haven’t visited us yet, stop by Booth #512 to meet our team and explore how we can help you overcome supply chain challenges. Our team of experts is available to discuss the latest advancements in hematology and give you a sneak peek at our upcoming innovations, designed to enhance biopharma logistics and cryopreservation. We look forward to insightful conversations and the opportunity to support your critical work. https://lnkd.in/gAMhQk8Q
-
Are you attending #ASH24? Visit us at Booth 512 to meet our team of experts and learn how we support the biopharma supply chain with precision, reliability, and innovation. Our attending team includes: * Mark Sawicki, Chief Executive Officer * Aruna Mor, Chief Commercial Officer * Dominic Clarke, Vice President, Technical Operations, IntegriCell * Amy Hines, Vice President, Apheresis Strategy and Sourcing * Mark Flower, Vice President, Business Development, Cryopreservation * Homero Mariduena, Executive Director, Global Strategic Accounts We look forward to productive conversations about advancing hematology and #EnablingTheOutcome for patients! Stop by to discuss your supply chain challenges and explore how we can help. https://lnkd.in/gAMhQk8Q
-
Cryoport Systems ($CYRX) is proud to be one of the shortlist finalists for the Simon Ellison Supply Chain Innovation Award, presented by Phacilitate Advanced Therapies. This award honors individuals and organizations who have made significant contributions to supply chain innovation, emphasizing its crucial role in improving patient outcomes. The winners will be announced on January 22, 2025, during Advanced Therapies Week. Best of luck to all the finalists! Learn about our unparalleled supply chain platform. https://lnkd.in/gp5vDENJ #ATA25 #EnablingTheOutcome
-
#CaseStudy: When Cryoport Systems’ client experienced a problem with shippers tilting during transit, compromising the holding time of the liquid nitrogen vapor coolant and jeopardizing a CAR T-cell immunotherapy clinical program, Cryoport solved it with a comprehensive solution. Read about how Cryoport can develop an integrated supply chain solution that addresses the intricate needs of each unique client: https://cyrx.co/3RxxI0A #EnablingTheOutcome $CYRX
-
Cryoport Systems is proud to announce an exciting partnership with Gulf Coast Regional Blood Center (GCRBC) designed to advance cellular therapy services. This alliance creates a streamline process leveraging GCRBC's Cellular Life Solutions ("CLS") program, which specializes in allogeneic donor recruitment, management, and apheresis collection, and Cryoport's industry-leading cryopreservation and biologistics expertise, creating a comprehensive and unified service offering for the life sciences community. Learn how this collaboration helps accelerate the development of lifesaving treatments for patients. https://lnkd.in/gqXYHBAY
Affiliated pages
Similar pages
Browse jobs
Stock
CYRX
NASDAQ
20 minutes delay
$8.30
-0.03 (-0.36%)
- Open
- 8.47
- Low
- 7.81
- High
- 8.57
Data from Refinitiv
See more info on